tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Boobalan Pachaiyappan, 37 are a BUY (100%).
Analyst Boobalan Pachaiyappan, currently employed at ROTH, carries an average stock price target met ratio of 25.71% that have a potential upside of 27.55% achieved within 53 days. Previously, Boobalan Pachaiyappan worked at ROTH MKM.
Boobalan Pachaiyappan’s has documented 73 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CING, Cingulate at 24-Aug-2026.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 11/12/2025. The price target of $13 was fulfilled within 21 days with a profit of $7.13 (121.47%) receiving and performance score of 57.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Sep-2026
$21
$12.19 (138.37%)
$10
Hold Since 31-Aug-2026
$25
$16.19 (183.77%)
$2
15 days ago
(31-Aug-2026)
2/8 (25%)
$14.99 (149.75%)
520
Hold Since 24-Aug-2026
$54
$45.19 (512.94%)
22 days ago
(24-Aug-2026)
5/7 (71.43%)
$45.71 (551.39%)
91
Hold Since 13-Aug-2026
$28
$19.19 (217.82%)
$3.5
1 months 2 days ago
(13-Aug-2026)
7/10 (70%)
$21.35 (321.05%)
216
Buy Since 14-Sep-2017
1 months 16 days ago
(30-Jul-2026)
10/20 (50%)
$26.6 (79.64%)
614
Which stock is Boobalan Pachaiyappan most bullish on?
What Year was the first public recommendation made by Boobalan Pachaiyappan?
